FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer By Ogkologos - September 19, 2025 397 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Cohort 2 of SunRISe-1 study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR ΠΩΣ ΠΡΟΚΑΛΕΙΤΑΙ January 18, 2019 Managing Side Effects with South Asian Foods July 19, 2022 Adjuvant Immunotherapy Approved for Some Patients with Lung Cancer October 26, 2021 Blinatumomab Increases Survival for Infants with an Aggressive Type of ALL June 8, 2023 Load more HOT NEWS Cure Probability Models for Evaluation of Patients with a Previous Cancer... Activity and Safety of Atezolizumab Combined with Carboplatin and Pemetrexed in... Pastor Opens Homeless Shelter And Moves In To Raise Money For... Registry Findings Highlight the Importance of Interdisciplinary Care in Rheumatic irAEs...
